| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.8581 | 48 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.704 | 35 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.7582 | 31 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.4546 | 39 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.8224 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.2807 | 49 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.3431 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.5443 | 47 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.8908 | 41 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.7787 | 36 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 54.0061 | 58 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 56.5656 | 61 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.3023 | 24 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.1999 | 28 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.0046 | 22 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.4105 | 15 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.587 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.463 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.0497 | 52 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.3847 | 24 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.2401 | 19 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.5939 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.7117 | 31 |